Search research articles
Contact Us
Filters
Showing results (61-70 of 108) with videos related to
Page
of 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 17, 2020
<sup>18</sup>F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 17, 2004
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types
Kjell Oberg, Lone Astrup, Barbro Eriksson, et al.
Molecular Imaging and Biology
|
February 15, 2022
Activity Dose Reduction in <sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 17, 2004
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview
Kjell Oberg, Lone Astrup, Barbro Eriksson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 11, 2023
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
Mathias Loft, Claes N Ladefoged, Camilla B Johnbeck, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2016
(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2
Ingrid H Olsen, Seppo W Langer, Birgitte H Federspiel, et al.
Current Treatment Options in Oncology
|
April 1, 2022
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Pernille Holmager, Seppo W Langer, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2015
64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients
Catarina Malmberg, Rasmus S Ripa, Camilla B Johnbeck, et al.
Journal of Neuroendocrinology
|
March 16, 2023
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma
Halfdan Sorbye, Enrique Grande, Marianne Pavel, et al.
Cancers
|
January 11, 2024
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients
Stine Møller, Seppo W Langer, Cecilie Slott, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 108) with videos related to
Sort By:
Page
of 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 17, 2020
<sup>18</sup>F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study
Tina Binderup, Ulrich Knigge, Camilla Bardram Johnbeck, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 17, 2004
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types
Kjell Oberg, Lone Astrup, Barbro Eriksson, et al.
Molecular Imaging and Biology
|
February 15, 2022
Activity Dose Reduction in <sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 17, 2004
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview
Kjell Oberg, Lone Astrup, Barbro Eriksson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 11, 2023
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose <sup>64</sup>Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms
Mathias Loft, Claes N Ladefoged, Camilla B Johnbeck, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2016
(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2
Ingrid H Olsen, Seppo W Langer, Birgitte H Federspiel, et al.
Current Treatment Options in Oncology
|
April 1, 2022
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
Pernille Holmager, Seppo W Langer, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 3, 2015
64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients
Catarina Malmberg, Rasmus S Ripa, Camilla B Johnbeck, et al.
Journal of Neuroendocrinology
|
March 16, 2023
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma
Halfdan Sorbye, Enrique Grande, Marianne Pavel, et al.
Cancers
|
January 11, 2024
Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients
Stine Møller, Seppo W Langer, Cecilie Slott, et al.
Page
of 11